Invesco Zacks Mid-Cap ETF (CZA)
| Assets | $180.08M |
| Expense Ratio | 0.69% |
| PE Ratio | 16.74 |
| Shares Out | 1.62M |
| Dividend (ttm) | $1.73 |
| Dividend Yield | 1.55% |
| Ex-Dividend Date | Dec 22, 2025 |
| Payout Frequency | Annual |
| Payout Ratio | 25.99% |
| Volume | 1,019 |
| Open | 109.97 |
| Previous Close | 111.20 |
| Day's Range | 109.97 - 111.52 |
| 52-Week Low | 90.08 |
| 52-Week High | 118.65 |
| Beta | 0.87 |
| Holdings | 105 |
| Inception Date | Apr 2, 2007 |
About CZA
Fund Home PageThe Invesco Zacks Mid-Cap ETF (CZA) is an exchange-traded fund that is based on the Zacks Mid Cap Core index. The fund holds a proprietary-selected portfolio of 100 mid-cap US stocks. The fund seeks to outperform pure market-cap indexes. CZA was launched on Apr 2, 2007 and is issued by Invesco.
Top 10 Holdings
21.38% of assets| Name | Symbol | Weight |
|---|---|---|
| Keysight Technologies, Inc. | KEYS | 2.82% |
| Westinghouse Air Brake Technologies Corporation | WAB | 2.38% |
| Nucor Corporation | NUE | 2.15% |
| PG&E Corporation | PCG | 2.13% |
| The Hartford Insurance Group, Inc. | HIG | 2.12% |
| Archer-Daniels-Midland Company | ADM | 2.06% |
| Nutrien Ltd. | NTR | 2.01% |
| State Street Corporation | STT | 1.96% |
| Arch Capital Group Ltd. | ACGL | 1.96% |
| GE HealthCare Technologies Inc. | GEHC | 1.81% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 22, 2025 | $1.72509 | Dec 26, 2025 |
| Dec 23, 2024 | $1.32017 | Dec 27, 2024 |
| Dec 18, 2023 | $1.28009 | Dec 22, 2023 |
| Dec 19, 2022 | $1.51937 | Dec 23, 2022 |
| Dec 20, 2021 | $0.85141 | Dec 31, 2021 |
| Dec 21, 2020 | $1.08369 | Dec 31, 2020 |
Performance
CZA had a total return of 8.95% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.27%.
News
Tech IPOs Poised For Return To Pre-Pandemic Normalcy In 2025
The new year is poised for a resurgence in tech IPOs, as lower interest rates and an investor shift to small- and mid-cap companies combine to create a more welcoming market for debuts. The current en...
CZA: Zacks Core Mid-Cap ETF Not What I Expected
Zacks Investment Research seeks to leverage the expertise of thousands of Wall Street researchers, reasoning that its clients can gain a competitive edge by following analyst upgrades and downgrades. ...
U.S. Equity ETFs: The Best And Worst Of 2022
This article summarizes the performance of the entire U.S. equity market by examining 1Y, 3Y, 5Y, and 10Y returns for 850+ ETFs across 40 categories. Major indices declined, but investing in Energy, H...